$1,199 – $1,299

6th European Biopharma Congress (cse) S

Event Information

Share this event

Date and Time

Location

Location

Hyatt Place Amsterdam Airport

800 Rijnlanderweg

2132 NN Hoofddorp

Netherlands

View Map

Refund Policy

Refund Policy

No Refunds

Event description

Description

6th European Biopharma Congress


About Conference

The Euro Biopharma 2018 offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions on the topics cell therapy, biotechnology,therapeutic biological products,gene therapy, Biosimilars, BABE, clinical trials, Drug discovery, current issues in Bioequivalence, Pharmaceutical Innovation in the 21st Century, new scientific approaches to international regulatory standards and Biophamaceutical companies &market analysis . The conference invites delegates from Biopharma laboratories, Pharmacists, Academicians, Clinicians, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects.

Conference Series llc LTD organizes a conference series of 1000+ Global Events inclusive of 600+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in Europe & Asia, USA with support from 1000 more scientific Societies and publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Why to Attend:

With all the scientific people over the world focused on learning about advancements in Pharma community. This is a best globalized opportunity to reach the largest assemblage of participants. We anticipate participants, renowned speakers and eminent delegates across the globe attending the conference to share their valuable presentation and galvanize the scientific community. Euro Biopharma2018 is to conduct the presentations, distribute information, meet with potential scientists, make a splash with new developments, and receive fame and recognition. Our services have always met with great achievement in Business Conferencing, the most recent and advanced techniques, developments, and the newest updates are the prominent features of the conference.

Conference highlights & tracks:

Cell Therapy, Therapeutic Biological Products, Gene Therapy, Biosimilars, Bioavailability/Bioequivalence, Clinical Trails, Drug Discovery, Biotechnology, Drug Delivery System, Drug Disposition & Pharmacokinetics, Drug Metabolism, Biopharmaceutical Companies & Market Analysis, Pharmaceutical Regulatory Affairs And Certifications


Sessions

Conference Series llc LTD invites all the participants from all over the world to attend European Biopharma Congress during September 18-19, 2018 in Amsterdam, Netherlands. Which includes prompt Keynote presentations, Oral talks, Poster presentations and Exhibitions.

The Euro Biopharma 2018 offers a best platform with its well organized scientific program to the audience which includes interactive panel discussions, keynote lectures, plenary talks and poster sessions on the topics Cell Therapy, Biopharmaceutics, Drug delivery, Biotechnology, Gene Therapy, Therapeutic Biological Products, BABE, Biosimilars, Clinical Trails, Drug Discovery, current issues in Bioequivalence, Pharmaceutical Innovation in the 21st Century, new scientific approaches to international regulatory standards. Biopharmaceutical Companies & Market Analysis, The conference invites delegates from Biopharma laboratories, Pharmacists, Academicians, Clinicians, Researchers, Health care professionals, students, business delegates and Young researchers across the globe providing a better podium, interconnecting the latest research, technological developments in the arena as well as therapeutic aspects.


Track 1: Biopharmaceutics: Drug Dscovery and Development

The field of new drug development has moved its focus from small-molecule compounds to large-molecule proteins and other biopharmaceuticals. These biopharmaceuticals have caused an archetype shift in disease cure and has led to an enhancement in the quality of life of patients with various diseases such as autoimmune diseases, refractory cancers biopharmaceuticals represent 7.5% of all drugs in the market and account for ~10% of the total expenses for marketed drugs. The usage of biopharmaceuticals are increasing at the rate >20% per year. They are already being used74% more than chemically derived pharmaceuticals, in life-saving or end-stage applications. Moreover, biopharmaceuticals covers > 30% of all pipeline research programs going-on at present which embraces all recombinant proteins, monoclonal antibodies, cytokines, peptides, vaccines, blood/plasma-derived products, non-recombinant culture-derived proteins, nucleic acid-based products (DNA, RNA or antisense oligonucleotides used for curative or in vivo diagnostic purposes), cells and tissues cultures. This view is possibly best understood by the public and mostly used by the people in the biopharmaceutical industry.


Track 2:Therapeutic Biological Products

Products that are obtained from specific organs or tissues said to correspond with the unhealthy organs or tissues of the recipient. Proponents claim that the recipient's body automatically transports the injected cells to the target organs, where they supposedly strengthen them and regenerate their structure. The organs and glands used in cell treatment include brain, pituitary, thyroid, adrenals, thymus, liver, kidney, pancreas, spleen, heart, ovary, testis, and parotid. Several different types of cell or cell extract can be given simultaneously - some practitioners routinely give up to 20 or more at once.


Track 3: Cellular and Gene Therapy

Cell therapy as performed by alternative medicine practitioners is very different from the controlled research done by conventional stem cell medical researchers. Alternative practitioners refer to their form of cell therapy by several other different names including Immunotherapy, Allogenic Cell Therapy and fresh Neural Stem cell therapy. Proponents of cell therapy claim that it has been used successfully to rebuild damaged cartilage in joints, repair spinal cord injuries, strengthen a weakened immune system, treat autoimmune diseases such as AIDS, and help patients with neurological disorders such as Alzheimer’s disease, Parkinson's disease and epilepsy.

Gene therapy and cell therapy are overlapping fields of biomedical research with the goals of repairing the direct cause of genetic diseases in the DNA or cellular population, respectively. The development of suitable gene therapy treatments for many genetic diseases and some acquired diseases has encountered many challenges and uncovered new insights into gene interactions and regulation. Further development often involves uncovering basic scientific knowledge of the affected tissues, cells, and genes, as well as redesigning vectors, formulations, and regulatory cassettes.


Track 4: Biologics and Biosimilars

The development of biologics calls for overcoming lot many challenges. With initial steps of concepts of biologics, their considerations, essentials for early clinical developments it is very much needed that proper scientific and strategic approaches are taken for the successful development of follow-on-biologics. Moreover, the need for overcoming the challenges continues in the late clinical steps, drug safety factors and labelling requirements. Also it is much required now to develop a drug product in accordance to quality by design (QBD). This Euro Biopharma 2017 conference will look at the multiple facets of current challenges in biosimilar development. This conference will focus on multiple aspects of biosimilar product development to successfully deliver safe, potential and efficacious biologic products to the market.


Track 5: Bioavailability & Bioequivalence studies of Biopharmaceuticals

The Bioavailability Bioequivalence Research Center aims to become a regional center of excellence for assuring the safety and efficacy of generic pharmaceutical products for human use. It plays a key role in the drug development period for both new drug products and their generic equivalents. These studies are also important in the post approval period in the presence of certain manufacturing changes. Information in the overall set of data that ensure the availability of safe and effective medicines to patients and practitioners can be discussed.


Track 6: Clinical Trials on Biopharmaceuticals Products

Clinical Trials is a multidisciplinary program with broad participation with members from around the globe focused on learning about clinical research and its advances. This is your best opportunity to reach the largest assemblage of participants from Clinical Trials community that is from academia, clinical research entities, medical groups, related associations, societies and also from government agencies, pharmaceutical, biomedical and medical device industries.

Clinical Trials will discuss various disciplines involved in the pre-clinical research, conduct of clinical trials; it will educate health care researchers about design, operation, organizing, research computing, regulatory aspects and reporting of clinical trials. It promotes better understanding by the general public about the importance of clinical trials in prevention, diagnosis and treatment of disease.


Track 7: Pharmacovigilance

Pharmacovigilance is to provide a complete information reagarding drug safety and various benefits associated with them. Pharmacovigilance can help in providing information of unintended and severe adverse events which could not be provided by clinical trials involving in-vivo method. Pharmacovigilance legislation gives an outlook on the rules and regulations to follow in Pharmacovigilance practice. A Pharma industry in the improvement of pharmacovigilance system is very crucial to maintain the safety data, Detection and Evaluation of drug safety signals through manual and medical devices reporting. Pharmacovigilance scope also deals as Ecopharmacovigilance (EPV), pharmaco environmentology and pharmacovigilance in herbal medicines. Drug Safety is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse side effects with pharmacological action of pharmaceutical products. According to US FDA a drug is regarded as safe by looking at side effects, its manufacturing process and results of animal testing and clinical trials.


Track 8: Drug Delivery System

Drug Delivery system attains greater global significance as Drug Delivery System plays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. This includes topics like lipid Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. The major part is to deliver an innovative speech on the latest Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to other drugs.


Track 9: Drug Disposition & Metabolism

Once a particular medicine is chosen, the principles of clinical pharmacokinetics are required to ensure the appropriate formulation of drug is chosen for an appropriate route of administration. On the basis of the patient’s drug handling parameters, which require an understanding of absorption, distribution, metabolism and excretion, the dosage regimen for the medicine in a particular patient can be developed. The pharmacist will then need to ensure that the appropriate regimen is prescribed to achieve optimal efficacy and minimal toxicity. Pharmacists then ensure that the appropriate monitoring is undertaken and that the patient receives the appropriate information to ensure compliance. Clinical pharmacokinetics is thus a fundamental knowledge base that pharmacists require to ensure effective practice of pharmaceutical care.


Track 10: Biopharmaceutical Companies & Market analysis

Pharmaceutical analytic market research deals with the collection, analysis, and interpretation of details and information relating to the market environment of a given pharmaceutical product – in general of a medical drug. The primary objective of pharmaceutical market research is to gain as realistic and objective as possible an impression of the marketing opportunities of a given pharmaceutical product, thus enabling the identification of the chances and risks associated with its development potential as early on as possible.


Track 11: Pharmaceutical Regulatory Affairs and IPR of Biopharmaceuticals

Good Manufacturing Practices quality of drugs is essentially the responsibility of manufacturers. GMP Guidelines are means to assure this very quality of drugs. CGMP refers to the Current Good Manufacturing Practice regulations enforced by the US Food and Drug Administration (FDA). CGMPs provide for systems that assure proper design, monitoring, and control of manufacturing processes and facilities. Adherence to the CGMP regulations assures the identity, strength, quality, and purity of drug products by requiring that manufacturers of medications adequately control manufacturing operations. GMP is actually good common sense quality management quality assurance GMP production and quality control.


Track 12: Biopharmaceutical Pharmacovigilance

The field of Pharmacovigilance is growing rapidly and its development is making tremendous impacts in medical sciences and pharmaceuticals. Euro Biopharma 2017 emphasizes on how the importance and significance can be gauged by the fact that it has made huge advancements over the course of time and is continuing to influence various sectors. With members from around the world focused on learning about Pharmacovigilance and its advances;


Track 13: Biotechnological Products

Pharmaceutical Biotechnology is an increasingly important area of science and technology, and contributes to design and delivery of new therapeutic drugs, the development of diagnostic agents for medical tests, and the beginnings of gene therapy for correcting the medical symptoms of hereditary diseases. Pharmaceutical Biotechnology is pioneering in the UK, providing a detailed insight into the technologies that allow the development and production of biopharmaceuticals that could lead to cures for most major diseases.


OCM for Euro Biopharma Series Conferences

Organizing Committee

OCM Member

Bimal roy krishna

Professor
Touro University
USA


OCM Member

Michael Retsky

Research Associate
Harvard University
Cambridge,USA


OCM Member

Alain L. Fymat

Professor
INTERNATIONAL INSTITUTE OF MEDICINE AND SCIENCE, INC
USA


OCM Member

Jabbari,Esmaiel

Professor
Columbia University of South Carolina
USA


OCM Member

GIULIO TARRO

President
Foundation de Beaumont Bonelli for cancer research
Italy


OCM Member

Debabrata Mukhopadhyay

Professor
Mayo Clinic College of Medicine
Florida, USA


OCM Member

Fabio Geremia

Senior Pharmaceutical Consultant
CTP System, Akka Technologies Group
ITALY


OCM Member

Heike Schoen

Managing Director
LUMIS International
Germany


OCM Member

Jorge Gonzalez Borroto

Pharmacovigilance Officer
Ferrer International S.A
Spain


OCM Member

Jianguo Yang

CEO
Abpro
China


OCM Member

Jun Xu

Professor
Sun Yat-Sen University
China


Please contact the event manager Marilyn (marilyn.b.turner@nyeventslist.com ) below for:
- Multiple participant discounts
- Price quotations or visa invitation letters
- Payment by alternate channels (PayPal, check, Western Union, wire transfers etc)
- Event sponsorships

NO REFUNDS ALLOWED ON REGISTRATIONS
Service fees included in this listing.
-----------------------------------------------------------------
This event is brought to you by:
Conference Series - NewYorkEventsList
http://www.NyEventsList.com
http://www.BostonEventsList.com
http://www.SFBayEventsList.com
-----------------------------------------------------------------

MYL180603CEV

Share with friends

Date and Time

Location

Hyatt Place Amsterdam Airport

800 Rijnlanderweg

2132 NN Hoofddorp

Netherlands

View Map

Refund Policy

No Refunds

Save This Event

Event Saved